Author | Alison R. Sehgal, MD | OncLive

Author | Alison R. Sehgal, MD

Articles

Dr. Sehgal on the Clinical Implications of CAR T-Cell Therapy in DLBCL

July 30, 2019

Video

Alison R. Sehgal, MD, assistant professor of medicine, hematologist/medical oncologist, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, discusses the clinical implications of CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL).

Dr. Sehgal on Managing CRS and Neurotoxicity From CAR T-Cell Therapy

July 09, 2019

Video

Alison R. Sehgal, MD, assistant professor of medicine, hematologist/medical oncologist, University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, discusses ways to manage cytokine release syndrome (CRS) and neurotoxicity associated with CAR T-cell therapy.

x